Prostatic Artery
Embolization Market Driven by Rising Geriatric Male Population

Market Overview

Prostatic artery embolization (PAE) is a
minimally invasive treatment procedure used for managing symptoms due to benign
prostatic hyperplasia (BPH) in men. It involves cutting off the blood supply to
the prostate gland by blocking the arteries that supply blood to the prostate,
which helps in reducing the prostate size. PAE provides relief from BPH related
symptoms such as difficulty initiating urination, weak stream, urgency, and
frequent urination. It is associated with benefits such as shorter hospital
stay and recovery time along with minimal post-procedure pain and side effects
as compared to traditional treatment options. The Global Prostatic Artery
Embolization Market is estimated to be valued at US$ 270.72 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period
from 2024 to 2031.



Key Takeaways

Key players operating in the Prostatic
Artery Embolization market Size are Ingersoll-Rand plc (Nexia), Vivint,
Inc., Protection One Alarm Monitoring, Inc., The ADT Corporation, Telus
Communications, Frontpoint Security Solutions, AT&T Inc., Johnson Controls,
Inc., Comcast Corporation, and CenturyLink, Inc. The growing geriatric male
population prone to BPH and rising preference for minimally invasive treatment
options are fueling the demand for PAE in the market. Major players are
expanding their presence globally, especially in emerging economies to tap the
significant growth opportunities in these untapped markets.



Market Drivers

The rising geriatric male population worldwide is a key driver for the
prostatic artery embolization market. According to the United Nations, the
population aged 60 years or older is growing at a rate of 3% every year
globally and is expected to double by 2050. Older men have higher risk of
developing BPH due to changes in hormone levels and enlargement of the prostate
gland. This is increasing the patient pool opting for PAE procedures for BPH
management. This market is thus driven by the increasing geriatric male
populace prone to BPH conditions treated with prostatic artery embolization.



The current geopolitical conflicts and uncertainties across several regions are
expected to impact the growth of the Prostatic Artery Embolization market. The
ongoing Russia-Ukraine war has disrupted global supply chains and economies.
Due to trade restrictions and sanctions, supply of certain medical devices and
components used in prostatic artery embolization procedures has been affected.
This is likely to hamper market expansion, especially in Eastern Europe, in the
short run. Furthermore, political instability and economic troubles in several
parts of Asia Pacific and Middle East & Africa may constrain healthcare
infrastructure development and investments in novel procedures. As a result,
market players may face challenges related to setting up new manufacturing
facilities or clinical research activities in these volatile regions over the
next few years.

Get more insights on Prostatic
Artery Embolization Market

Also read related article on Prostatic
Artery Embolization Market